Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

eye disease

POPULAR ARTICLES

pharmaceutical investing

Clearside Biomedical Completes Enrollment for Phase 1/2 Trial

medical device investing

TearLab Osmolarity System Receives Mexican Regulatory Approval

Clearside Biomedical Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Zuprata™

LATEST ARTICLES

Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™

Nicox Receives Complete Response from FDA Related for AC-170

Ocular Therapeutix™ Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP

Will GenSight's Product Candidate, GS010, Boost the Bottom Line?

Pharmaceutical Investing

pharmaceutical investing

Aerie Pharmaceuticals Sees Stock Soar

Ocular Therapeutix™ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)

Biotech Investing

SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85

Novaliq Announces Last Patient Enrolled in Phase 2 Clinical Trial of CyclASol® for the Treatment of Moderate to Severe Dry Eye Disease

Latest News

Development update - Collie graphite micronising facility

West High Yield Resources Ltd. Announces Proceeds from Exercise of Warrants

Empire Metals Limited Announces Major Drilling Campaign Targeting Maiden MRE

Pinnacle Reports High-Grade Gold-Silver on Surface and in Underground Workings at El Potrero Project

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake